Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roly Gosling

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
Medrxiv : the Preprint Server for Health Sciences|October 4, 2023
Targeted malaria elimination interventions reduce <i>Plasmodium falciparum</i> infections up to 3 kilometers awayJade Benjamin-Chung, Haodong Li, Anna Nguyen, et al.
Nature Health|June 1, 2026
Mapping the local effectiveness of mass drug administration for malaria using transportability methodsMichelle E Roh, Yanwei Tong, Gabriella Barratt Heitmann, et al.
Nature Medicine|July 4, 2024
Extension of efficacy range for targeted malaria-elimination interventions due to spillover effectsJade Benjamin-Chung, Haodong Li, Anna Nguyen, et al.
Malaria Journal|March 18, 2018
Low risk of recurrence following artesunate-Sulphadoxine-pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the SudanMuzamil Mahdi Abdel Hamid, Kamala Thriemer, Maha E Elobied, et al.
Infectious Diseases of Poverty|May 16, 2022
Could China's journey of malaria elimination extend to Africa?Duoquan Wang, Shan Lv, Wei Ding, et al.
The Lancet. Infectious Diseases|February 25, 2016
Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trialAlassane Dicko, Joelle M Brown, Halimatou Diawara, et al.
BMJ Open|June 23, 2022
Cost and cost effectiveness of reactive case detection (RACD), reactive focal mass drug administration (rfMDA) and reactive focal vector control (RAVC) to reduce malaria in the low endemic setting of Namibia: an analysis alongside a 2×2 factorial design cluster randomised controlled trialHenry Ntuku, Cara Smith-Gueye, Valerie Scott, et al.
Plos Medicine|May 9, 2024
Measuring protective efficacy and quantifying the impact of drug resistance: A novel malaria chemoprevention trial design and methodologyAndria Mousa, Gina Cuomo-Dannenburg, Hayley A Thompson, et al.
Malaria Journal|November 9, 2016
Comparison of molecular quantification of Plasmodium falciparum gametocytes by Pfs25 qRT-PCR and QT-NASBA in relation to mosquito infectivityHelmi Pett, Bronner P Gonçalves, Alassane Dicko, et al.
BMJ Open|January 29, 2018
Study protocol for a cluster randomised controlled factorial design trial to assess the effectiveness and feasibility of reactive focal mass drug administration and vector control to reduce malaria transmission in the low endemic setting of NamibiaOliver F Medzihradsky, Immo Kleinschmidt, Davis Mumbengegwi, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Medrxiv : the Preprint Server for Health Sciences|October 4, 2023
Targeted malaria elimination interventions reduce <i>Plasmodium falciparum</i> infections up to 3 kilometers awayJade Benjamin-Chung, Haodong Li, Anna Nguyen, et al.
Nature Health|June 1, 2026
Mapping the local effectiveness of mass drug administration for malaria using transportability methodsMichelle E Roh, Yanwei Tong, Gabriella Barratt Heitmann, et al.
Nature Medicine|July 4, 2024
Extension of efficacy range for targeted malaria-elimination interventions due to spillover effectsJade Benjamin-Chung, Haodong Li, Anna Nguyen, et al.
Malaria Journal|March 18, 2018
Low risk of recurrence following artesunate-Sulphadoxine-pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the SudanMuzamil Mahdi Abdel Hamid, Kamala Thriemer, Maha E Elobied, et al.
Infectious Diseases of Poverty|May 16, 2022
Could China's journey of malaria elimination extend to Africa?Duoquan Wang, Shan Lv, Wei Ding, et al.
The Lancet. Infectious Diseases|February 25, 2016
Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trialAlassane Dicko, Joelle M Brown, Halimatou Diawara, et al.
BMJ Open|June 23, 2022
Cost and cost effectiveness of reactive case detection (RACD), reactive focal mass drug administration (rfMDA) and reactive focal vector control (RAVC) to reduce malaria in the low endemic setting of Namibia: an analysis alongside a 2×2 factorial design cluster randomised controlled trialHenry Ntuku, Cara Smith-Gueye, Valerie Scott, et al.
Plos Medicine|May 9, 2024
Measuring protective efficacy and quantifying the impact of drug resistance: A novel malaria chemoprevention trial design and methodologyAndria Mousa, Gina Cuomo-Dannenburg, Hayley A Thompson, et al.
Malaria Journal|November 9, 2016
Comparison of molecular quantification of Plasmodium falciparum gametocytes by Pfs25 qRT-PCR and QT-NASBA in relation to mosquito infectivityHelmi Pett, Bronner P Gonçalves, Alassane Dicko, et al.
BMJ Open|January 29, 2018
Study protocol for a cluster randomised controlled factorial design trial to assess the effectiveness and feasibility of reactive focal mass drug administration and vector control to reduce malaria transmission in the low endemic setting of NamibiaOliver F Medzihradsky, Immo Kleinschmidt, Davis Mumbengegwi, et al.
Pageof 12